Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Psychiatry/Psychology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Memory Loss Clinical Trials

A listing of Memory Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (74) clinical trials

This study is for patients with cognitive impairment or mild Alzheimer’s disease. Alzheimer’s disease is a slow progressive disease of the brain that affects memory and brain function. Currently available medications for Alzheimer’s disease provide limited symptomatic benefit and do not significantly change the course of the illness. This study ...

Phase

Some forgetfulness can be a normal part of aging. However, some people have more memory problems than other people their age. This condition is called mild cognitive impairment, or MCI. People with MCI can take care of themselves and do their normal activities, but they may lose things often, forget ...

Phase

SPRI is currently participating in a multi-center, 24-month clinical evaluation of an investigational drug for people suffering from mild cognitive impairment (MCI) or mild Alzheimer’s disease (AD).

Phase N/A

SPRI Clinical Trials of Brooklyn, under the sponsorship of Suven Life Sciences, is currently participating in the clinical evaluation of the safety and effectiveness of an investigational drug in persons with moderate dementia due to Alzheimer’s disease.

Phase

Primary objective: to evaluate the efficacy of AZD3293 on cognitive and functional outcomes in patients with early Alzheimer’s disease (AD) as measured by the Clinical Dementia Rating - Sum of Boxes (CDR-SB) score. Early AD is defined as the continuum of patients with mild cognitive impairment (MCI) due to AD ...

Phase N/A

A Research Study is being conducted to evaluate an oral investigational medication that may help slow down the progression of what could be very early Alzheimer’s disease. Prodromal Alzheimer’s disease is the very early stage of the disease when minor symptoms first appear. A diagnosis can only be confirmed through ...

Phase N/A

A Research Study is being conducted to evaluate an oral investigational medication that may help slow down the progression of what could be very early Alzheimer’s disease. Prodromal Alzheimer’s disease is the very early stage of the disease when minor symptoms first appear. A diagnosis can only be confirmed through ...

Phase N/A

California Neuroscience Research is conducting a research study on the effectiveness and safety of an investigational medication or placebo in patients with mild Alzheimer’s disease. The study has up to 31 office visits over up to 40 months. Participants will receive an investigational medication or placebo monthly by subcutaneous injection. ...

Phase N/A

Meridien Research is participating in a nationwide research study evaluating the safety and effectiveness of an investigational medication, AC-1204, for those with mild to moderate Alzheimer's disease.

Phase N/A

With age, some memory loss is normal. But it can also indicate the beginnings of Alzheimer’s. If you’ve noticed more forgetfulness and a decreased ability to function over the last year, you may be in the beginning stages of Alzheimer’s. If you have not been diagnosed and are between ages ...

Phase